about
A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bonesThe bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statinsMedication-related osteonecrosis of the jaw: Clinical and practical guidelinesBisphosphonates: from bench to bedsideThe neurologic complications of Paget's disease.Anti-tumour activity of bisphosphonates in human myeloma cells.Total hip arthroplasty in patients with Paget's disease of bone: A systematic review.Surgical management of Paget's disease.The pharmacology of bisphosphonates and new insights into their mechanisms of action.Paget's disease: treatment results and expectations with present therapies.Discussion: Newer bisphosphonates in the treatment of Paget's disease of bone: where we are and where we want to go.Pathophysiology of bone pain: a review.Cementless total hip arthroplasty in Paget's disease of bone: a retrospective review.Monostotic Paget's disease of the second metacarpalPhosphate: known and potential roles during development and regeneration of teeth and supporting structures.Medical management of Paget's disease of bone: indications for treatment and review of current therapies.How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.Current options for the treatment of Paget's disease of the bone.Prevention of bisphosphonates-induced osteonecrosis.PSMA-PET/CT-Positive Paget Disease in a Patient with Newly Diagnosed Prostate Cancer: Imaging and Bone Biopsy FindingsDesign and Biological Evaluation of Delivery Systems Containing BisphosphonatesDiagnosis and treatment of Paget's disease of bone: a mini-review.A novel inhibitory mechanism of nitrogen-containing bisphosphonate on the activity of Cl- extrusion in osteoclasts.Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.Factors associated with self-rated health in patients with Paget's disease of bone.Long-term release of clodronate from biodegradable microspheresRe-treatment of relapsed Paget's disease of bone with zoledronic acid: results from an open-label study.Paget's Disease of the Bone.Clodronate combined with a surfactant (Tween 20) does not improve osseointegration: a rabbit immunohistomorphometric study.Efficacy of pamidronate in complex regional pain syndrome type I.Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.Dynamic contrast-enhanced MRI for monitoring bisphosphonate therapy in Paget's disease of bone.Preparation and evaluation of floating risedronate sodium-Gelucire 43/01 formulations.Skeletal dissemination in Paget's disease of the spine.Paget's disease of bone (osteitis deformans).Polyostotic Paget's Disease with Sarcomatous Change in a Skull Lesion. A Case Report of Imaging Findings.Alendronate alters osteoblast activities.Zoledronate: efficacy and safety.
P2860
Q24298582-07546402-BCE8-451D-B9E8-BBA6BE142EBDQ24684244-7B4CD906-C307-4B4A-B8C4-BD6EFAF73B99Q26749965-B791CAF4-EAB3-4904-96BF-B71753FFAD4DQ28251212-2FF708A5-B1D8-4919-85E8-078B6C32F8C6Q30582267-9CDB3843-839C-4462-86CA-3CC7390BA506Q33536291-20A8B505-DEA3-4931-94A6-55A61110322FQ33577356-1A9ED540-4724-491B-977B-A07D29FF3568Q33746132-035676F4-1CA2-4387-A5F5-B11A9E150B8AQ33746152-A684D552-2194-48DE-B32B-088E0AB545B7Q33746160-0BC5972B-F933-4821-A7F1-9D5A593D6074Q33746165-B2A07F13-605C-4FCF-A568-78E353A69416Q34323748-C5F812A2-4200-455B-BFFD-49F124F36709Q34337149-CA70F34F-E045-4589-B754-E18BC51B92F1Q34904749-4B377C4A-3EE8-40C6-9342-C0EBB79567ACQ35920063-C59C595A-3996-4E78-BAB1-CA9534999B9EQ36710192-B38334E9-EDC2-4ABB-AC58-76FA5704B440Q37113976-677A23B9-4F79-4042-8123-AE69BC79131FQ37358122-096E93D3-C0DD-4B71-98C0-460564DB0962Q37430252-ECFC9928-CF7A-409A-9FBE-E751C1DFE418Q37726312-CFC5430B-96A3-4274-BFB5-DBB062595113Q37731222-A9BFBCE1-0036-4F6D-A9DD-CB20F27198E4Q38171737-C5018C05-DA16-437D-8F7E-81E5E3A56F0BQ39169911-6F8E839A-2AD7-47FB-98AC-0EDEC951FFDDQ39609021-464D663C-B60C-4508-AA8A-AC26E4A5DA9AQ40794980-78D93BFB-27C8-492D-80F7-4B3129003AACQ41852284-A32CC49B-9C11-4BBB-AD6C-9E41DE784270Q41978637-1795047A-0A0D-4F8A-93B2-01A8EE8EF4DCQ42523547-1A93F080-B801-4696-A083-7D9C0C84B697Q43263186-440BEC5E-6B52-44B8-A673-06CAA240FDFAQ45058939-259CA068-F0FB-4139-8984-2530C24051A1Q45105237-14DFE236-DF56-4D3D-8C02-70BE0E35B291Q45755065-F0201B47-45AA-4DDB-9DEF-BE86301AC9A3Q46818235-CD428257-8258-4C06-AD20-4121B2C1EA29Q48222155-7ECBB9B7-2811-4C23-9A3D-C4895D7BB4D7Q50504567-494CC106-4E33-4F0C-9BC4-A473FEE5C245Q50800448-D01CC614-307F-458A-B957-610015136FEEQ51559081-EB764E60-763A-4F83-8629-930757725A81Q53209081-F60C5F4D-16CC-4993-A956-0E655586649F
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The management of Paget's disease of bone.
@en
type
label
The management of Paget's disease of bone.
@en
prefLabel
The management of Paget's disease of bone.
@en
P1476
The management of Paget's disease of bone.
@en
P2093
P304
P356
10.1056/NEJM199702203360807
P407
P577
1997-02-01T00:00:00Z